This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
March 4, 2013 /PRNewswire/ -- Global business integration software provider SEEBURGER today announced the availability of Legisym's Express222™ cloud-based
Controlled Substance Ordering System (CSOS) solution as an add-on to SEEBURGER's
business integration platform for healthcare customers seeking a cost-effective CSOS solution with no software installation requirements for themselves or their trading partners. The SEEBURGER Business Integration Suite (BIS) can be delivered in tandem with Express222 as a managed service, providing an end-to-end hosted B2B and CSOS solution. Alternatively, SEEBURGER BIS can be deployed behind the corporate firewall in a private cloud or licensed scenario.
Click to Tweet:
The new partnership enables SEEBURGER customers to take advantage of the only completely Web-based CSOS solution that meets the strict DEA order management requirements for the safe and secure transport of controlled substance pharmaceuticals. Winner of the
HDMA Distribution Management Award for innovation in health distribution processes, Legisym's Express222 enables suppliers of all sizes and requirements – from the occasional Class II buyer to the frequent multiple-order buyer – to eliminate the paper DEA Form 222 while also avoiding the large upfront investment, annual maintenance fees, technical complexities and extensive support needs of client/server CSOS solutions.
The joint SEEBURGER/Legisym solution is being demonstrated at SEEBURGER's Booth 204 and Legisym's Booth 703 at this week's Healthcare Distribution Management Association (HDMA) conference in
Strong Customer Support
The ability to combine the SEEBURGER and Legisym solutions in a hosted environment, and avoid the time and expense of integrating the CSOS solution into the organization's B2B platform, provides an efficient, easy-to-deploy and DEA-compliant strategy for expediting the exchange of controlled substances among manufacturers, wholesalers, pharmacies and reverse distributors. That includes the ability to leverage modern process improvements such as batch signing with POA certificate management capabilities favored by mass retailers and reverse distributors to centralize digital signing for thousands of locations.